Efficacy/Safety Study of Deferiprone Compared to Deferasirox in Paediatric Patients

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
Multicentre, randomised, open label, non-inferiority active-controlled trial to evaluate efficacy and safety of a 12-months treatment with deferiprone (DFP) at dose of 75-100 mg/kg/day versus deferasirox (DFX) at dose of 20-40 mg/kg/day in paediatric patients (1 month \< 18 years old) affected by hereditary haemoglobinopathies and requiring frequent transfusions and chelation.
Epistemonikos ID: d169542be5095d8261d602a71174f8502d5ac38a
First added on: May 11, 2024